Defining Success after Latarjet: A Comprehensive Review of Clinical and Patient-related Outcomes
Journal of Bone and Joint Diseases · 2026-01 · 41 (1) · 9-14
DOI: 10.4103/jbjd.jbjd_28_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Joint Diseases, online erschienen am 21.04.2026. Verfasst von Rajat Kapoor und 3 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The Latarjet procedure is an established treatment for recurrent anterior shoulder instability with glenoid bone loss. While its efficacy in preventing re-dislocation is well-documented, a comprehensive analysis defining success through a combination of clinical and patient-reported outcomes is required.
Objectives
This study aimed to evaluate the multi-dimensional outcomes of the Latarjet procedure in a young, active cohort. Materials and Methods: A prospective single-center study was conducted involving 30 patients (mean age: 28.4 ± 6.1 years; 86.7% male) with significant glenoid bone loss (22.3% ± 4.8%) who underwent the open Latarjet procedure. Outcomes were assessed preoperatively and postoperatively with a mean follow-up of 15.2 months. Primary outcomes were recurrence of instability and return-to-sport/work (RTS) rates. Secondary outcomes included patient-reported outcome measures (PROMs)—Rowe, Western Ontario Shoulder Instability Index (WOSI), American Shoulder and Elbow Surgeons (ASES), and Visual Analog Scale (VAS) for pain—and active range of motion (ROM).
Results
The recurrence rate was 3.3% (1 patient). The RTS rate was 93.3%, with 80.0% of all patients returning to the same or a higher level of activity. All PROMs demonstrated significant improvement ( P < 0.001): Rowe score improved from 36.2 ± 10.5 to 91.5 ± 8.4, WOSI from 45.5% ± 12.1% to 88.2% ± 9.8%, ASES from 48.8 ± 11.3 to 90.1 ± 7.6, and VAS pain decreased from 6.8 ± 1.5 to 1.2 ± 1.1. Postoperative ROM also significantly improved, with external rotation increasing from 48.3° ± 9.6° to 58.9° ± 7.2°. The complication rate was 13.3%, including transient neuropraxia and a superficial infection.
Conclusion
The Latarjet procedure produces excellent, multi-dimensional success, defined by a very low recurrence rate, a high rate of return to high-demand activities, significant improvements in patient-reported function and quality of life, and preserved motion. It remains a highly reliable solution for restoring shoulder stability and function in patients with significant bone loss.
Zitieren
APA
Kapoor, R., Sharma, Y., Sharma, B., & Mittal, V. (2026). Defining Success after Latarjet: A Comprehensive Review of Clinical and Patient-related Outcomes. Journal of Bone and Joint Diseases, 41(1), 9-14. https://doi.org/10.4103/jbjd.jbjd_28_25
Vancouver
Kapoor R, Sharma Y, Sharma B, Mittal V. Defining Success after Latarjet: A Comprehensive Review of Clinical and Patient-related Outcomes. Journal of Bone and Joint Diseases. 2026;41(1):9-14. doi:10.4103/jbjd.jbjd_28_25
BibTeX
@article{Kapoor2026,
author = {Kapoor, Rajat and Sharma, Yashvardhan and Sharma, Brijesh and Mittal, Vivek},
title = {Defining Success after Latarjet: A Comprehensive Review of Clinical and Patient-related Outcomes},
journal = {Journal of Bone and Joint Diseases},
year = {2026},
volume = {41},
number = {1},
pages = {9--14},
doi = {10.4103/jbjd.jbjd_28_25}
}
EUVIMED